PARALLEL VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION FOR FULMINANT MYOCARDITIS COMPLICATED BY REFRACTORY VENTRICULAR ARRHYTHMIA: A CASE REPORT
Main Article Content
Abstract
Objective: To report a case of refractory ventricular arrhythmia secondary to fulminant myocarditis successfully treated with parallel veno-arterial extracorporeal membrane oxygenation (parallel V-A ECMO) combined with therapeutic plasma exchange as an adjunctive treatment for refractory ventricular arrhythmia.
Methods: A 36-year-old female patient was admitted with acute myocarditis. She subsequently developed acute heart failure, cardiogenic shock, and ventricular arrhythmia requiring circulatory support with V-A ECMO. As the ventricular arrhythmia became refractory, a second V-A ECMO system was initiated in parallel, and therapeutic plasma exchange was performed to support arrhythmia control.
Results: After 3 days of treatment with parallel V-A ECMO and two sessions of plasma exchange with a total volume of 12 liters of fresh frozen plasma, the ventricular arrhythmia improved, allowing removal of the second V-A ECMO system. After 7 days of ECMO support, myocardial contractility improved and the first V-A ECMO system was successfully discontinued. The patient was subsequently transferred to the Cardiology Department, with recovery of cardiac contractile function, and was discharged with a left ventricular ejection fraction of 50%.
Conclusion: Parallel ECMO may be safer than hybrid ECMO and may help achieve adequate tissue perfusion in patients with fulminant myocarditis complicated by refractory ventricular arrhythmia. Therapeutic plasma exchange, by reducing circulating myocardial stimulatory substances, may serve as an adjunctive treatment option for refractory ventricular arrhythmia.
Keywords
fulminant myocarditis, refractory ventricular arrhythmia, V-A ECMO, parallel V-A ECMO
Article Details
References
2. Shah A, Dave S, Goerlich CE, Kaczorowski DJ. Hybrid and parallel extracorporeal membrane oxygenation circuits. JTCVS Tech. 2021 Feb 24; 8:77-85.
3. Parisi N, Nadim M, Akgun Y. Mechanisms of immune modulation by therapeutic plasma exchange. Transfus Apher Sci. 2026 Feb;65(1):104371.
4. Giordani AS, Baritussio A, Vicenzetto C, Peloso-Cattini MG, Pontara E, Bison E et al. Fulminant Myocarditis: When One Size Does Not Fit All - A Critical Review of the Literature. Eur Cardiol. 2023 Apr 20;18:e15.
5. Schulz-Menger J, Collini V, Gröschel J, Adler Y, Brucato A, Christian V, ESC Scientific Document Group. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025 Oct 22;46(40):3952-4041.
6. Nunez JI, Grandin EW, Reyes-Castro T, Sabe M, Quintero P, Motiwala S et al. Outcomes With Peripheral Venoarterial Extracorporeal Membrane Oxygenation for Suspected Acute Myocarditis: 10-Year Experience From the Extracorporeal Life Support Organization Registry. Circ Heart Fail. 2023 Jul;16(7):e010152.
7. Koniman R, Kaushik M. Therapeutic plasma exchange in critical illness. J Transl Crit Care Med. 2023;5(4):e00010.